Taiwan TCMs Set To Hit Mainland Market
This article was originally published in PharmAsia News
Executive Summary
At a recent forum on cross-strait TCM cooperation and technology exchange, Xiamen Traditional Chinese Medicine signed a letter of intent for TCM industry collaboration with Taiwan's three pharmaceutical companies - Sun Ten Pharmaceutical, Sheng Chang Pharmaceutical and Chuang Song Zong Pharmaceutical. The China firm promises to use its marketing channels to bring Taiwan-made health products and TCM into the mainland market. In addition, Taiwan and China will leverage on Xiamen as a platform for TCM communication and will enhance cooperation on raw material purchases, herbal slice processing, herbal extract production, TCM formulation innovation, new drug development and establishing marketing channels. Both parties also reached an understanding on codeveloping TCM business opportunities in a global market. (Click here for more - Chinese Language)